ViewRay® to Partcipate in the Cantor Global Healthcare Conference
ViewRay, Inc. (NASDAQ: VRAY) announced participation in the Cantor Global Healthcare Conference on September 28, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
ViewRay, Inc. (NASDAQ: VRAY) announced participation in the Cantor Global Healthcare Conference on September 28, 2021. CEO Scott Drake and CFO Zach Stassen will engage in a fireside chat at 10:00 a.m. Eastern Time. Investors can access an audio webcast of the presentation via the company's investor relations website, with a replay available for seven days following the event.
ViewRay specializes in the MRIdian® MR-Guided Radiation Therapy System, addressing unique challenges in radiation oncology.
Positive
- Company participation in a significant healthcare conference may enhance visibility and investor interest.
- The event offers an opportunity for management to discuss future strategies directly with investors.
Negative
- None.
Details
News Market Reaction – VRAY
The recorded move for VRAY in the trading session of this news was -1.06%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CLEVELAND, Sept. 16, 2021 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will participate in the Cantor Global Healthcare Conference. Scott Drake, President and Chief Executive Officer, and Zach Stassen, Chief Financial Officer, will participate in a fireside chat at 10:00 a.m. Eastern Time on Tuesday, September 28, 2021.
An audio webcast of the Company's presentation will be available on the investor relations section of ViewRay's website at http://investors.viewray.com/events-and-presentations/upcoming-events. A replay of the webcast will be available for 7 days after the date of the presentation.
About ViewRay®
ViewRay, Inc. (Nasdaq: VRAY), designs, manufactures, and markets the MRIdian® MR-Guided Radiation Therapy System. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purpose-built to address specific challenges, including beam distortion, skin toxicity, and other concerns that potentially may arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc.
View original content:https://www.prnewswire.com/news-releases/viewray-to-partcipate-in-the-cantor-global-healthcare-conference-301379106.html
SOURCE ViewRay, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.